We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Cell Analysis Software Speeds Search for Potential Eye Cancer Treatment

By LabMedica International staff writers
Posted on 27 Feb 2012
A new cell tracing algorithm has quickened the discovery of an important, previously unknown role for the tumor suppressor gene Rb, which, when abnormally inactivated, is the probable trigger of the aggressive childhood cancer retinoblastoma.

Intensive efforts are being made to identify and characterize the roles of Rb in eye development, but studies have been greatly hampered by limitations of technology available for finding retinal anomalies at the cellular level.

A major limitation has now been removed by the specialized cell tracing, image analysis program developed for a study of the Rb gene published December 27, 2012, in the journal Proceedings of the National Academy of Sciences of the USA (PNAS). More...
The program allowed researchers to analyze thousands of cells instead of just a few dozen. It could also be used as the basis for developing algorithms specialized for analyzing morphological changes in large numbers of other neurons and other cell types.


"Our paper shows that horizontal neurons known to be deficient in this gene exhibited abnormalities in the way their connecting dendrites were organized after a certain number of days after birth," said author Ryan Kerekes, PhD, of the Department of Energy's Oak Ridge National Laboratories (ORNL; Oak Ridge, TN, USA).

The study, led by senior author Michael A. Dyer, PhD, was a collaborative effort among investigators at ORNL, University of Tennessee (UT) at Knoxville (USA), UT at Memphis (USA), St. Jude Children Research Hospital (Memphis, TN, USA), and the Universidade Federal do Rio de Janeiro (Rio de Janeiro, Brazil).

Dr. Kerekes and ORNL team members Dr. Shaun Gleason and Dr. Mahmut Karakaya developed the computer program and automated tool that traces the very complex and intricate dendritic arbor. This allowed scientists to draw a line along each branch in the neuron's tree of connectors so the branch can be measured in terms of length, angle, and other parameters.

"Previously, this was a very time-consuming and labor-intensive process," Kerekes said. "Existing commercial software tools were not tuned to this particular data and, as a result, produced too many tracing errors."

As a result, only a handful of cells could be analyzed in sufficient detail, according to Kerekes, who noted that the ORNL tracing algorithms achieves the level of accuracy required to analyze thousands of developing neurons.

Related Links:
Oak Ridge (US) National Laboratories
University of Tennessee, Knoxville
Universidade Federal do Rio de Janeiro



Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
ESR Analyzer
miniiSED™
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.